Alkaline Phosphatase
Test Summary
Serum alkaline phosphatase levels are of interest in the diagnosis of hepatobiliary disorders and bone disease associated with increased osteoblastic activity. Moderate elevations of alkaline phosphatase may be seen in several conditions that do not involve the liver or bone. Among these are Hodgkin's disease, congestive heart failure, ulcerative colitis, regional enteritis, and intra-abdominal bacterial infections. Elevations are also observed during the third trimester of pregnancy.
Aliases
- N/A
Specimen Collection
Special Instructions
N/A
Preferred Specimen
1 mL serum collected in a serum separator tube (SST)
Minimum Volume
0.5 mL
Instructions
Administration of STRENSIQ may interfere in certain assays and may falsely elevate values. For patients receiving STRENSIQ, consideration should be given to using alternate methods.
Patient Preparation
N/A
Storage
N/A
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 7 days
- Refrigerated: 7 days
- Frozen: 28 days
Limitations
N/A
Other Acceptable Specimens
Plasma collected in: Sodium heparin (green-top) tube or lithium heparin (green-top) tube
Unacceptable Specimens
Anticoagulants other than heparin
Order Code
ALKPHS
EPIC (Premier) Code
N/A
Includes
N/A
CPT Code
- 84075
Billing Code
- 700000
CPT Statement
Methodology
Spectrophotometry (SP)
FDA Status
FDA Approved
Physician Attestation of Informed Consent
N/A
Testing Laboratory
Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly VA, 20153
14225 Newbrook Drive
Chantilly VA, 20153
Reference Range
Male (U/L) | Female (U/L) | |
0-6 Days | 46-245 | 46-245 |
7-14 Days | 69-306 | 69-306 |
15 Days-<1 Month | 113-412 | 113-412 |
1-5 Months | 104-450 | 104-450 |
6-11 Months | 100-334 | 100-334 |
1-9 Years | 117-311 | 117-311 |
10 Years | 128-396 | 128-396 |
11 Years | 125-428 | 100-429 |
12 Years | 123-426 | 69-296 |
13 Years | 100-417 | 58-258 |
14 Years | 78-326 | 51-179 |
15 Years | 65-278 | 45-150 |
16 Years | 56-234 | 41-140 |
17-19 Years | 46-169 | 36-128 |
20-49 Years | 36-130 | 31-125 |
>49 Years | 35-144 | 37-153 |
Setup Schedule / Expected Turnaround Time
Daily, Report available: 1 day
Specimen Collection
Special Instructions
N/A
Preferred Specimen
1 mL serum collected in a serum separator tube (SST)
Minimum Volume
0.5 mL
Instructions
Administration of STRENSIQ may interfere in certain assays and may falsely elevate values. For patients receiving STRENSIQ, consideration should be given to using alternate methods.
Patient Preparation
N/A
Storage
N/A
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 7 days
- Refrigerated: 7 days
- Frozen: 28 days
Limitations
N/A
Other Acceptable Specimens
Plasma collected in: Sodium heparin (green-top) tube or lithium heparin (green-top) tube
Unacceptable Specimens
Anticoagulants other than heparin
Result Information
Methodology
Spectrophotometry (SP)
Testing Laboratory
N/A
Reference Range
Male (U/L) | Female (U/L) | |
0-6 Days | 46-245 | 46-245 |
7-14 Days | 69-306 | 69-306 |
15 Days-<1 Month | 113-412 | 113-412 |
1-5 Months | 104-450 | 104-450 |
6-11 Months | 100-334 | 100-334 |
1-9 Years | 117-311 | 117-311 |
10 Years | 128-396 | 128-396 |
11 Years | 125-428 | 100-429 |
12 Years | 123-426 | 69-296 |
13 Years | 100-417 | 58-258 |
14 Years | 78-326 | 51-179 |
15 Years | 65-278 | 45-150 |
16 Years | 56-234 | 41-140 |
17-19 Years | 46-169 | 36-128 |
20-49 Years | 36-130 | 31-125 |
>49 Years | 35-144 | 37-153 |
Setup Schedule / Expected Turnaround Time
Daily, Report available: 1 day